CIP
LMAT icon

Convergence Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Convergence Investment Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25,178
Closed -$843K – 339
2018
Q2 		$843K Buy
+25,178
New +$896K 0.12% 226

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Convergence Investment Partners's LMAT Position: Q3 2018 in Review

Convergence Investment Partners sold out of LeMaitre Vascular (LMAT) in Q3 2018, closing a stake of 25,178 shares — an estimated $843K sold.

Convergence Investment Partners first reported a position in LMAT in Q2 2018 and held it in 1 quarter. The position peaked at $843K in Q2 2018. 156 funds tracked by Wall St. Rank hold LMAT as of Q3 2018.

  • Convergence Investment Partners reported no remaining LeMaitre Vascular position as of Q3 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 25,178 LeMaitre Vascular shares in Q3 2018, an estimated $843K.
  • Convergence Investment Partners first reported a position in LeMaitre Vascular in Q2 2018 and held it in 1 quarter.
  • Convergence Investment Partners's LeMaitre Vascular position peaked at $843K in Q2 2018.
  • 156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2018.

Based on Convergence Investment Partners's 13F filing for Q3 2018, filed 13 Nov 2018.